Gilead Sciences (GILD)
Nasdaq
Gilead Sciences (GILD) last traded at $168.52, up 0.98% on Nasdaq as of 9 Nov 2026, 20:56 GMT+0530.
Key statistics
Gilead Sciences analyst forecast
Scroll here to load data.
Gilead Sciences stock research: financials and ownership
Gilead Sciences revenue, operating income and net income
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 5.00M |
| Shares Outstanding | 1.26K |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Gilead Sciences revenue by segment
Scroll here to load data.
Gilead Sciences revenue by region
Scroll here to load data.
Gilead Sciences stock margins
Scroll here to load data.
Gilead Sciences historical valuation
Scroll here to load data.
Gilead Sciences annual returns
Scroll here to load data.
Gilead Sciences financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
Related Articles & Updates
TechGraph News · 2026-10-18The Connected Exchange: NCDEX CTO Balkrishna Shankwalker on the Future of the Commodity Market
TechGraph News · 2026-10-15NumanCap Review 2026 | Markets, Margin and Mobile
TechGraph News · 2026-10-01What Does India’s First Tokenised Bond Pilot Mean for the Debt Market?
TechGraph News · 2026-09-15Javier Olivan Plans $1.04 Million Meta Share Sale
TechGraph News · 2026-09-13NVIDIA Awards 172,507 Shares to EVP Nicholas Parker
TechGraph News · 2026-09-13Meta CPO Chris Cox Sells Shares Worth $13 Mn
Gilead Sciences fair value
Discounted cash flow fair value compared with the market price.
Scroll here to load data.
Gilead Sciences company rating
Composite rating and the factor scores behind it.
Scroll here to load data.
Gilead Sciences financial ratios
Trailing twelve month ratios.
Scroll here to load data.
Gilead Sciences peers
Related companies.
Scroll here to load data.
Gilead Sciences earnings calls
Transcripts listed for this ticker.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About Gilead Sciences
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy. In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed…
From the companyLearn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Company profile
Gilead Sciences executives and management
Gilead Sciences — frequently asked questions
What is the Gilead Sciences price today?
Gilead Sciences (GILD) last traded at $168.52, up 0.98% on Nasdaq as of 9 Nov 2026, 20:56 GMT+0530.
Where is Gilead Sciences listed?
Gilead Sciences trades as GILD on Nasdaq.
What was the previous close of GILD?
The previous close of GILD was $166.89.
What is the day range of GILD?
The latest day range of GILD is $166.40 to $168.52.
What is the trading volume of GILD?
The latest recorded trading volume of GILD is 1.35M.
What is the ISIN of Gilead Sciences?
The ISIN of Gilead Sciences is US3755581036.
In which currency does GILD trade?
GILD is quoted in USD on Nasdaq.
How often is the GILD price updated?
Prices refresh about once a minute while the market is open. When the market is closed the last recorded price is shown with its time. Prices can be delayed by the exchange.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.